Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Objective Response”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Testing effectiveness (Phase 2)Ended earlyNCT01466868
What this trial is testing

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Centre Leon Berard 22
Testing effectiveness (Phase 2)Looking for participantsNCT06125834
What this trial is testing

Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy

Who this might be right for
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University 36
Large-scale testing (Phase 3)Ended earlyNCT01271114
What this trial is testing

Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

Who this might be right for
Septic ShockSepsis-associated Hypotension
Hospital General de Ciudad Real 21
Testing effectiveness (Phase 2)Ended earlyNCT00620100
What this trial is testing

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

Who this might be right for
Breast Neoplasms
Sanofi 2
Not applicableUnknownNCT03892577
What this trial is testing

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Who this might be right for
Objective Response RateProgression-free SurvivalOverall Survival+4 more
Peking Union Medical College Hospital 3,000
Post-approval studies (Phase 4)UnknownNCT02687724
What this trial is testing

Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis

Who this might be right for
Colitis
University College Dublin 136
Testing effectiveness (Phase 2)UnknownNCT02124317
What this trial is testing

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Chinese PLA General Hospital 60
Early research (Phase 1)Study completedNCT00481728
What this trial is testing

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Who this might be right for
Overactive Bladder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 28
Large-scale testing (Phase 3)UnknownNCT00975793
What this trial is testing

Australasian Resuscitation In Sepsis Evaluation Randomised Controlled Trial

Who this might be right for
Severe Sepsis
Belinda Howe 1,600
Testing effectiveness (Phase 2)Study completedNCT01323400
What this trial is testing

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
GIST
Centre Leon Berard 81
Testing effectiveness (Phase 2)UnknownNCT05760196
What this trial is testing

Radiotherapy Combined With PD-1 Inhibitor and GM-CSF for Advanced Recurrent Metastatic Head and Neck Tumors

Who this might be right for
Objective Response Rate
Xiangpan Li 56
Not applicableStudy completedNCT00407823
What this trial is testing

Comparison of Pediatric Septic Shock Treatment With and Without Central Venous Oxygen Saturation Monitoring

Who this might be right for
Severe SepsisSeptic Shock
University of Sao Paulo 268
Testing effectiveness (Phase 2)Looking for participantsNCT06848842
What this trial is testing

Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Liver Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Ended earlyNCT00661011
What this trial is testing

Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy

Who this might be right for
Non Small Cell Lung Carcinoma
European Lung Cancer Working Party 75
Not applicableStudy completedNCT03279367
What this trial is testing

Optimisation of Hearing Aid Fitting

Who this might be right for
Hearing LossHearing Abnormality
University of Southampton 20
Not applicableEnded earlyNCT02365688
What this trial is testing

Hemodynamic Response During Goal Directed Fluid Therapy in the OR

Who this might be right for
Hemodynamic Instability
Medtronic - MITG 18
Not applicableStudy completedNCT01739946
What this trial is testing

Urinary Biomarkers For Objective Measurement Of InterStim® Response In Over Active Bladder (OAB) Patients.

Who this might be right for
Overactive Bladder
Michael Chancellor, MD 30
Testing effectiveness (Phase 2)WithdrawnNCT01328106
What this trial is testing

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Who this might be right for
GNA11 Mutation-positive Metastatic MelanomaGNAQ Mutation-positive Metastatic MelanomaCancer+1 more
GlaxoSmithKline
Not applicableNot Yet RecruitingNCT06447285
What this trial is testing

Early, Objective Detection of Autism.

Who this might be right for
Autism Spectrum Disorder
SensoDetect 300
Large-scale testing (Phase 3)Study completedNCT01973907
What this trial is testing

Pilot Study for the SQUEEZE Trial

Who this might be right for
Septic Shock
McMaster Children's Hospital 53
Load More Results